nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—HRH1—atherosclerosis	0.245	1	CbGaD
Fexofenadine—Pimozide—Ezetimibe—atherosclerosis	0.157	0.521	CrCrCtD
Fexofenadine—Fluspirilene—Ezetimibe—atherosclerosis	0.144	0.479	CrCrCtD
Fexofenadine—SLCO2B1—Niacin—atherosclerosis	0.0434	0.113	CbGbCtD
Fexofenadine—SLCO2B1—Rosuvastatin—atherosclerosis	0.0369	0.0962	CbGbCtD
Fexofenadine—SLCO2B1—Pravastatin—atherosclerosis	0.0336	0.0875	CbGbCtD
Fexofenadine—SLCO1B3—Rosuvastatin—atherosclerosis	0.0328	0.0854	CbGbCtD
Fexofenadine—SLCO1B3—Pravastatin—atherosclerosis	0.0298	0.0777	CbGbCtD
Fexofenadine—SLCO1A2—Rosuvastatin—atherosclerosis	0.0202	0.0527	CbGbCtD
Fexofenadine—SLCO1B1—Rosuvastatin—atherosclerosis	0.0191	0.0497	CbGbCtD
Fexofenadine—SLCO1B1—Ezetimibe—atherosclerosis	0.0191	0.0497	CbGbCtD
Fexofenadine—SLCO1A2—Simvastatin—atherosclerosis	0.0188	0.049	CbGbCtD
Fexofenadine—SLCO1A2—Pravastatin—atherosclerosis	0.0184	0.048	CbGbCtD
Fexofenadine—SLCO1A2—Lovastatin—atherosclerosis	0.0184	0.048	CbGbCtD
Fexofenadine—SLCO1B1—Simvastatin—atherosclerosis	0.0178	0.0462	CbGbCtD
Fexofenadine—SLCO1B1—Pravastatin—atherosclerosis	0.0174	0.0453	CbGbCtD
Fexofenadine—SLCO1B1—Lovastatin—atherosclerosis	0.0174	0.0453	CbGbCtD
Fexofenadine—CYP2D6—Niacin—atherosclerosis	0.00606	0.0158	CbGbCtD
Fexofenadine—ABCB1—Ezetimibe—atherosclerosis	0.00547	0.0142	CbGbCtD
Fexofenadine—ABCB1—Simvastatin—atherosclerosis	0.00509	0.0132	CbGbCtD
Fexofenadine—ABCB1—Pravastatin—atherosclerosis	0.00498	0.013	CbGbCtD
Fexofenadine—ABCB1—Lovastatin—atherosclerosis	0.00498	0.013	CbGbCtD
Fexofenadine—CYP2D6—Simvastatin—atherosclerosis	0.00479	0.0125	CbGbCtD
Fexofenadine—CYP2D6—Pravastatin—atherosclerosis	0.00469	0.0122	CbGbCtD
Fexofenadine—CYP2D6—Lovastatin—atherosclerosis	0.00469	0.0122	CbGbCtD
Fexofenadine—Upset stomach—Lovastatin—atherosclerosis	0.000998	0.0205	CcSEcCtD
Fexofenadine—Upset stomach—Simvastatin—atherosclerosis	0.000934	0.0192	CcSEcCtD
Fexofenadine—Accidental injury—Rosuvastatin—atherosclerosis	0.000872	0.0179	CcSEcCtD
Fexofenadine—Nightmare—Rosuvastatin—atherosclerosis	0.000745	0.0153	CcSEcCtD
Fexofenadine—Accidental injury—Lovastatin—atherosclerosis	0.000739	0.0152	CcSEcCtD
Fexofenadine—Viral infection—Ezetimibe—atherosclerosis	0.00071	0.0146	CcSEcCtD
Fexofenadine—Sleep disorder—Rosuvastatin—atherosclerosis	0.000647	0.0133	CcSEcCtD
Fexofenadine—Bepotastine—HRH1—atherosclerosis	0.000619	0.306	CrCbGaD
Fexofenadine—Viral infection—Pravastatin—atherosclerosis	0.000612	0.0126	CcSEcCtD
Fexofenadine—Injury—Rosuvastatin—atherosclerosis	0.000609	0.0125	CcSEcCtD
Fexofenadine—Nightmare—Simvastatin—atherosclerosis	0.000591	0.0121	CcSEcCtD
Fexofenadine—Nightmare—Pravastatin—atherosclerosis	0.000534	0.011	CcSEcCtD
Fexofenadine—Injury—Lovastatin—atherosclerosis	0.000516	0.0106	CcSEcCtD
Fexofenadine—Sleep disorder—Simvastatin—atherosclerosis	0.000513	0.0105	CcSEcCtD
Fexofenadine—Cetirizine—HRH1—atherosclerosis	0.000492	0.244	CrCbGaD
Fexofenadine—Pain in extremity—Lovastatin—atherosclerosis	0.000475	0.00976	CcSEcCtD
Fexofenadine—Atrial fibrillation—Simvastatin—atherosclerosis	0.000469	0.00964	CcSEcCtD
Fexofenadine—Pain in extremity—Ezetimibe—atherosclerosis	0.000466	0.00958	CcSEcCtD
Fexofenadine—Sleep disorder—Pravastatin—atherosclerosis	0.000464	0.00954	CcSEcCtD
Fexofenadine—Injury—Pravastatin—atherosclerosis	0.000437	0.00898	CcSEcCtD
Fexofenadine—Buclizine—HRH1—atherosclerosis	0.000431	0.214	CrCbGaD
Fexofenadine—Atrial fibrillation—Niacin—atherosclerosis	0.00043	0.00885	CcSEcCtD
Fexofenadine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000416	0.00856	CcSEcCtD
Fexofenadine—Sinusitis—Rosuvastatin—atherosclerosis	0.000405	0.00833	CcSEcCtD
Fexofenadine—Abdominal discomfort—Lovastatin—atherosclerosis	0.000393	0.00809	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000374	0.00769	CcSEcCtD
Fexofenadine—Abdominal discomfort—Simvastatin—atherosclerosis	0.000368	0.00757	CcSEcCtD
Fexofenadine—Nasopharyngitis—Pravastatin—atherosclerosis	0.000359	0.00738	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000357	0.00734	CcSEcCtD
Fexofenadine—Sinusitis—Lovastatin—atherosclerosis	0.000343	0.00706	CcSEcCtD
Fexofenadine—Sinusitis—Ezetimibe—atherosclerosis	0.000337	0.00692	CcSEcCtD
Fexofenadine—Flatulence—Rosuvastatin—atherosclerosis	0.000332	0.00684	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000322	0.00663	CcSEcCtD
Fexofenadine—Sinusitis—Simvastatin—atherosclerosis	0.000321	0.0066	CcSEcCtD
Fexofenadine—Angioedema—Rosuvastatin—atherosclerosis	0.000308	0.00634	CcSEcCtD
Fexofenadine—Flushing—Lovastatin—atherosclerosis	0.000305	0.00627	CcSEcCtD
Fexofenadine—Flushing—Ezetimibe—atherosclerosis	0.000299	0.00615	CcSEcCtD
Fexofenadine—Cough—Rosuvastatin—atherosclerosis	0.000294	0.00605	CcSEcCtD
Fexofenadine—Sinusitis—Pravastatin—atherosclerosis	0.00029	0.00597	CcSEcCtD
Fexofenadine—Myalgia—Rosuvastatin—atherosclerosis	0.000287	0.00591	CcSEcCtD
Fexofenadine—Flushing—Simvastatin—atherosclerosis	0.000285	0.00586	CcSEcCtD
Fexofenadine—Flatulence—Lovastatin—atherosclerosis	0.000282	0.00579	CcSEcCtD
Fexofenadine—Back pain—Lovastatin—atherosclerosis	0.000277	0.00569	CcSEcCtD
Fexofenadine—Flatulence—Ezetimibe—atherosclerosis	0.000276	0.00568	CcSEcCtD
Fexofenadine—Infection—Rosuvastatin—atherosclerosis	0.000274	0.00563	CcSEcCtD
Fexofenadine—Fluspirilene—HRH1—atherosclerosis	0.000273	0.135	CrCbGaD
Fexofenadine—Back pain—Ezetimibe—atherosclerosis	0.000271	0.00558	CcSEcCtD
Fexofenadine—Vision blurred—Lovastatin—atherosclerosis	0.000269	0.00554	CcSEcCtD
Fexofenadine—Flatulence—Simvastatin—atherosclerosis	0.000264	0.00542	CcSEcCtD
Fexofenadine—Flushing—Niacin—atherosclerosis	0.000262	0.00538	CcSEcCtD
Fexofenadine—Angioedema—Lovastatin—atherosclerosis	0.000261	0.00537	CcSEcCtD
Fexofenadine—Flushing—Pravastatin—atherosclerosis	0.000258	0.0053	CcSEcCtD
Fexofenadine—Angioedema—Ezetimibe—atherosclerosis	0.000256	0.00527	CcSEcCtD
Fexofenadine—Vision blurred—Simvastatin—atherosclerosis	0.000252	0.00518	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000251	0.00516	CcSEcCtD
Fexofenadine—Insomnia—Rosuvastatin—atherosclerosis	0.000249	0.00512	CcSEcCtD
Fexofenadine—Palpitations—Ezetimibe—atherosclerosis	0.000248	0.0051	CcSEcCtD
Fexofenadine—Cough—Ezetimibe—atherosclerosis	0.000245	0.00503	CcSEcCtD
Fexofenadine—Angioedema—Simvastatin—atherosclerosis	0.000244	0.00503	CcSEcCtD
Fexofenadine—Myalgia—Lovastatin—atherosclerosis	0.000243	0.00501	CcSEcCtD
Fexofenadine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000242	0.00498	CcSEcCtD
Fexofenadine—Flatulence—Niacin—atherosclerosis	0.000242	0.00498	CcSEcCtD
Fexofenadine—Tension—Niacin—atherosclerosis	0.000241	0.00496	CcSEcCtD
Fexofenadine—Myalgia—Ezetimibe—atherosclerosis	0.000239	0.00491	CcSEcCtD
Fexofenadine—Nervousness—Niacin—atherosclerosis	0.000238	0.0049	CcSEcCtD
Fexofenadine—Flatulence—Pravastatin—atherosclerosis	0.000238	0.0049	CcSEcCtD
Fexofenadine—Dry mouth—Lovastatin—atherosclerosis	0.000238	0.0049	CcSEcCtD
Fexofenadine—Tension—Pravastatin—atherosclerosis	0.000237	0.00488	CcSEcCtD
Fexofenadine—Pain—Rosuvastatin—atherosclerosis	0.000235	0.00484	CcSEcCtD
Fexofenadine—Nervousness—Pravastatin—atherosclerosis	0.000235	0.00483	CcSEcCtD
Fexofenadine—Dry mouth—Ezetimibe—atherosclerosis	0.000233	0.0048	CcSEcCtD
Fexofenadine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000233	0.0048	CcSEcCtD
Fexofenadine—Infection—Lovastatin—atherosclerosis	0.000232	0.00477	CcSEcCtD
Fexofenadine—Vision blurred—Niacin—atherosclerosis	0.000231	0.00476	CcSEcCtD
Fexofenadine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000229	0.00471	CcSEcCtD
Fexofenadine—Vision blurred—Pravastatin—atherosclerosis	0.000228	0.00469	CcSEcCtD
Fexofenadine—Myalgia—Simvastatin—atherosclerosis	0.000228	0.00468	CcSEcCtD
Fexofenadine—Infection—Ezetimibe—atherosclerosis	0.000227	0.00468	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000225	0.00463	CcSEcCtD
Fexofenadine—Angioedema—Niacin—atherosclerosis	0.000224	0.00461	CcSEcCtD
Fexofenadine—Angioedema—Pravastatin—atherosclerosis	0.000221	0.00454	CcSEcCtD
Fexofenadine—Urticaria—Rosuvastatin—atherosclerosis	0.000219	0.0045	CcSEcCtD
Fexofenadine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000218	0.00449	CcSEcCtD
Fexofenadine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000218	0.00448	CcSEcCtD
Fexofenadine—Palpitations—Niacin—atherosclerosis	0.000217	0.00446	CcSEcCtD
Fexofenadine—Infection—Simvastatin—atherosclerosis	0.000217	0.00446	CcSEcCtD
Fexofenadine—Cough—Niacin—atherosclerosis	0.000214	0.00441	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000213	0.00437	CcSEcCtD
Fexofenadine—Insomnia—Lovastatin—atherosclerosis	0.000211	0.00434	CcSEcCtD
Fexofenadine—Cough—Pravastatin—atherosclerosis	0.000211	0.00434	CcSEcCtD
Fexofenadine—Myalgia—Niacin—atherosclerosis	0.000209	0.0043	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000209	0.00429	CcSEcCtD
Fexofenadine—Dyspnoea—Lovastatin—atherosclerosis	0.000208	0.00428	CcSEcCtD
Fexofenadine—Insomnia—Ezetimibe—atherosclerosis	0.000207	0.00426	CcSEcCtD
Fexofenadine—Myalgia—Pravastatin—atherosclerosis	0.000206	0.00423	CcSEcCtD
Fexofenadine—Dyspepsia—Lovastatin—atherosclerosis	0.000205	0.00422	CcSEcCtD
Fexofenadine—Dry mouth—Niacin—atherosclerosis	0.000204	0.0042	CcSEcCtD
Fexofenadine—Pimozide—HRH1—atherosclerosis	0.000204	0.101	CrCbGaD
Fexofenadine—Dyspnoea—Ezetimibe—atherosclerosis	0.000204	0.0042	CcSEcCtD
Fexofenadine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000203	0.00417	CcSEcCtD
Fexofenadine—Dyspepsia—Ezetimibe—atherosclerosis	0.000201	0.00414	CcSEcCtD
Fexofenadine—Fatigue—Lovastatin—atherosclerosis	0.000201	0.00414	CcSEcCtD
Fexofenadine—Anaphylactic shock—Niacin—atherosclerosis	0.0002	0.00412	CcSEcCtD
Fexofenadine—Pain—Lovastatin—atherosclerosis	0.0002	0.0041	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000199	0.00409	CcSEcCtD
Fexofenadine—Asthenia—Rosuvastatin—atherosclerosis	0.000198	0.00406	CcSEcCtD
Fexofenadine—Insomnia—Simvastatin—atherosclerosis	0.000197	0.00406	CcSEcCtD
Fexofenadine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000197	0.00406	CcSEcCtD
Fexofenadine—Fatigue—Ezetimibe—atherosclerosis	0.000197	0.00406	CcSEcCtD
Fexofenadine—Infection—Pravastatin—atherosclerosis	0.000196	0.00403	CcSEcCtD
Fexofenadine—Pain—Ezetimibe—atherosclerosis	0.000196	0.00402	CcSEcCtD
Fexofenadine—Tachycardia—Niacin—atherosclerosis	0.000196	0.00402	CcSEcCtD
Fexofenadine—Pruritus—Rosuvastatin—atherosclerosis	0.000195	0.00401	CcSEcCtD
Fexofenadine—Dyspnoea—Simvastatin—atherosclerosis	0.000195	0.004	CcSEcCtD
Fexofenadine—Dyspepsia—Simvastatin—atherosclerosis	0.000192	0.00395	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000191	0.00392	CcSEcCtD
Fexofenadine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000188	0.00387	CcSEcCtD
Fexofenadine—Fatigue—Simvastatin—atherosclerosis	0.000188	0.00387	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000187	0.00385	CcSEcCtD
Fexofenadine—Pain—Simvastatin—atherosclerosis	0.000187	0.00384	CcSEcCtD
Fexofenadine—Urticaria—Lovastatin—atherosclerosis	0.000185	0.00381	CcSEcCtD
Fexofenadine—Abdominal pain—Lovastatin—atherosclerosis	0.000184	0.00379	CcSEcCtD
Fexofenadine—Body temperature increased—Lovastatin—atherosclerosis	0.000184	0.00379	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000183	0.00375	CcSEcCtD
Fexofenadine—Dizziness—Rosuvastatin—atherosclerosis	0.000182	0.00374	CcSEcCtD
Fexofenadine—Urticaria—Ezetimibe—atherosclerosis	0.000182	0.00374	CcSEcCtD
Fexofenadine—Insomnia—Niacin—atherosclerosis	0.000181	0.00373	CcSEcCtD
Fexofenadine—Abdominal pain—Ezetimibe—atherosclerosis	0.000181	0.00372	CcSEcCtD
Fexofenadine—Body temperature increased—Ezetimibe—atherosclerosis	0.000181	0.00372	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00018	0.0037	CcSEcCtD
Fexofenadine—Dyspnoea—Niacin—atherosclerosis	0.000179	0.00367	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000178	0.00367	CcSEcCtD
Fexofenadine—Insomnia—Pravastatin—atherosclerosis	0.000178	0.00367	CcSEcCtD
Fexofenadine—Somnolence—Niacin—atherosclerosis	0.000178	0.00366	CcSEcCtD
Fexofenadine—Dyspepsia—Niacin—atherosclerosis	0.000176	0.00363	CcSEcCtD
Fexofenadine—Dyspnoea—Pravastatin—atherosclerosis	0.000176	0.00362	CcSEcCtD
Fexofenadine—Dyspepsia—Pravastatin—atherosclerosis	0.000174	0.00357	CcSEcCtD
Fexofenadine—Rash—Rosuvastatin—atherosclerosis	0.000174	0.00357	CcSEcCtD
Fexofenadine—Dermatitis—Rosuvastatin—atherosclerosis	0.000173	0.00357	CcSEcCtD
Fexofenadine—Urticaria—Simvastatin—atherosclerosis	0.000173	0.00357	CcSEcCtD
Fexofenadine—Abdominal pain—Simvastatin—atherosclerosis	0.000173	0.00355	CcSEcCtD
Fexofenadine—Body temperature increased—Simvastatin—atherosclerosis	0.000173	0.00355	CcSEcCtD
Fexofenadine—Headache—Rosuvastatin—atherosclerosis	0.000172	0.00355	CcSEcCtD
Fexofenadine—Hypersensitivity—Lovastatin—atherosclerosis	0.000172	0.00354	CcSEcCtD
Fexofenadine—Pain—Niacin—atherosclerosis	0.000171	0.00352	CcSEcCtD
Fexofenadine—Fatigue—Pravastatin—atherosclerosis	0.00017	0.0035	CcSEcCtD
Fexofenadine—Pain—Pravastatin—atherosclerosis	0.000169	0.00347	CcSEcCtD
Fexofenadine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000169	0.00347	CcSEcCtD
Fexofenadine—Asthenia—Lovastatin—atherosclerosis	0.000167	0.00344	CcSEcCtD
Fexofenadine—Pruritus—Lovastatin—atherosclerosis	0.000165	0.0034	CcSEcCtD
Fexofenadine—Asthenia—Ezetimibe—atherosclerosis	0.000164	0.00338	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Niacin—atherosclerosis	0.000164	0.00337	CcSEcCtD
Fexofenadine—Nausea—Rosuvastatin—atherosclerosis	0.000164	0.00336	CcSEcCtD
Fexofenadine—Pruritus—Ezetimibe—atherosclerosis	0.000162	0.00333	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000161	0.00332	CcSEcCtD
Fexofenadine—Hypersensitivity—Simvastatin—atherosclerosis	0.000161	0.00331	CcSEcCtD
Fexofenadine—Diarrhoea—Lovastatin—atherosclerosis	0.00016	0.00328	CcSEcCtD
Fexofenadine—Urticaria—Niacin—atherosclerosis	0.000159	0.00327	CcSEcCtD
Fexofenadine—Body temperature increased—Niacin—atherosclerosis	0.000158	0.00326	CcSEcCtD
Fexofenadine—Abdominal pain—Niacin—atherosclerosis	0.000158	0.00326	CcSEcCtD
Fexofenadine—Urticaria—Pravastatin—atherosclerosis	0.000157	0.00322	CcSEcCtD
Fexofenadine—Asthenia—Simvastatin—atherosclerosis	0.000157	0.00322	CcSEcCtD
Fexofenadine—Diarrhoea—Ezetimibe—atherosclerosis	0.000157	0.00322	CcSEcCtD
Fexofenadine—Abdominal pain—Pravastatin—atherosclerosis	0.000156	0.00321	CcSEcCtD
Fexofenadine—Body temperature increased—Pravastatin—atherosclerosis	0.000156	0.00321	CcSEcCtD
Fexofenadine—Pruritus—Simvastatin—atherosclerosis	0.000154	0.00318	CcSEcCtD
Fexofenadine—Dizziness—Lovastatin—atherosclerosis	0.000154	0.00317	CcSEcCtD
Fexofenadine—Dizziness—Ezetimibe—atherosclerosis	0.000151	0.00311	CcSEcCtD
Fexofenadine—Diarrhoea—Simvastatin—atherosclerosis	0.000149	0.00307	CcSEcCtD
Fexofenadine—Vomiting—Lovastatin—atherosclerosis	0.000148	0.00305	CcSEcCtD
Fexofenadine—Hypersensitivity—Niacin—atherosclerosis	0.000148	0.00304	CcSEcCtD
Fexofenadine—Rash—Lovastatin—atherosclerosis	0.000147	0.00303	CcSEcCtD
Fexofenadine—Dermatitis—Lovastatin—atherosclerosis	0.000147	0.00302	CcSEcCtD
Fexofenadine—Headache—Lovastatin—atherosclerosis	0.000146	0.00301	CcSEcCtD
Fexofenadine—Vomiting—Ezetimibe—atherosclerosis	0.000146	0.00299	CcSEcCtD
Fexofenadine—Hypersensitivity—Pravastatin—atherosclerosis	0.000145	0.00299	CcSEcCtD
Fexofenadine—Dizziness—Simvastatin—atherosclerosis	0.000144	0.00297	CcSEcCtD
Fexofenadine—Rash—Ezetimibe—atherosclerosis	0.000144	0.00297	CcSEcCtD
Fexofenadine—Dermatitis—Ezetimibe—atherosclerosis	0.000144	0.00296	CcSEcCtD
Fexofenadine—Asthenia—Niacin—atherosclerosis	0.000144	0.00296	CcSEcCtD
Fexofenadine—Headache—Ezetimibe—atherosclerosis	0.000143	0.00295	CcSEcCtD
Fexofenadine—Pruritus—Niacin—atherosclerosis	0.000142	0.00292	CcSEcCtD
Fexofenadine—Asthenia—Pravastatin—atherosclerosis	0.000142	0.00291	CcSEcCtD
Fexofenadine—Pruritus—Pravastatin—atherosclerosis	0.00014	0.00287	CcSEcCtD
Fexofenadine—Vomiting—Simvastatin—atherosclerosis	0.000139	0.00285	CcSEcCtD
Fexofenadine—Nausea—Lovastatin—atherosclerosis	0.000139	0.00285	CcSEcCtD
Fexofenadine—Rash—Simvastatin—atherosclerosis	0.000138	0.00283	CcSEcCtD
Fexofenadine—Dermatitis—Simvastatin—atherosclerosis	0.000137	0.00283	CcSEcCtD
Fexofenadine—Diarrhoea—Niacin—atherosclerosis	0.000137	0.00282	CcSEcCtD
Fexofenadine—Headache—Simvastatin—atherosclerosis	0.000137	0.00281	CcSEcCtD
Fexofenadine—Nausea—Ezetimibe—atherosclerosis	0.000136	0.0028	CcSEcCtD
Fexofenadine—Diarrhoea—Pravastatin—atherosclerosis	0.000135	0.00278	CcSEcCtD
Fexofenadine—Dizziness—Niacin—atherosclerosis	0.000133	0.00273	CcSEcCtD
Fexofenadine—Dizziness—Pravastatin—atherosclerosis	0.00013	0.00268	CcSEcCtD
Fexofenadine—Nausea—Simvastatin—atherosclerosis	0.00013	0.00267	CcSEcCtD
Fexofenadine—Vomiting—Niacin—atherosclerosis	0.000127	0.00262	CcSEcCtD
Fexofenadine—Rash—Niacin—atherosclerosis	0.000126	0.0026	CcSEcCtD
Fexofenadine—Dermatitis—Niacin—atherosclerosis	0.000126	0.0026	CcSEcCtD
Fexofenadine—Headache—Niacin—atherosclerosis	0.000126	0.00258	CcSEcCtD
Fexofenadine—Vomiting—Pravastatin—atherosclerosis	0.000125	0.00258	CcSEcCtD
Fexofenadine—Rash—Pravastatin—atherosclerosis	0.000124	0.00256	CcSEcCtD
Fexofenadine—Dermatitis—Pravastatin—atherosclerosis	0.000124	0.00256	CcSEcCtD
Fexofenadine—Headache—Pravastatin—atherosclerosis	0.000124	0.00254	CcSEcCtD
Fexofenadine—Nausea—Niacin—atherosclerosis	0.000119	0.00245	CcSEcCtD
Fexofenadine—Nausea—Pravastatin—atherosclerosis	0.000117	0.00241	CcSEcCtD
Fexofenadine—HRH1—Signaling by GPCR—EDNRA—atherosclerosis	8.84e-06	0.000455	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	8.81e-06	0.000454	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CETP—atherosclerosis	8.69e-06	0.000448	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—GHRL—atherosclerosis	8.61e-06	0.000444	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APOB—atherosclerosis	8.57e-06	0.000441	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	8.5e-06	0.000438	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CCL2—atherosclerosis	8.49e-06	0.000437	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL4—atherosclerosis	8.45e-06	0.000435	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTM1—atherosclerosis	8.34e-06	0.000429	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—SCARB1—atherosclerosis	8.33e-06	0.000429	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—KNG1—atherosclerosis	8.32e-06	0.000429	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.29e-06	0.000427	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AGTR1—atherosclerosis	8.27e-06	0.000426	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ABCA1—atherosclerosis	8.2e-06	0.000422	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	8.19e-06	0.000422	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—LPL—atherosclerosis	8.18e-06	0.000422	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.11e-06	0.000418	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GPX1—atherosclerosis	7.99e-06	0.000411	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOA2—atherosclerosis	7.89e-06	0.000407	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—HMGCR—atherosclerosis	7.86e-06	0.000405	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CD36—atherosclerosis	7.78e-06	0.000401	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.71e-06	0.000397	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KNG1—atherosclerosis	7.56e-06	0.000389	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—UTS2—atherosclerosis	7.53e-06	0.000388	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AGTR1—atherosclerosis	7.51e-06	0.000387	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCG1—atherosclerosis	7.49e-06	0.000386	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	7.38e-06	0.00038	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MTHFR—atherosclerosis	7.37e-06	0.00038	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	7.25e-06	0.000374	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARA—atherosclerosis	7.23e-06	0.000372	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CX3CR1—atherosclerosis	7.22e-06	0.000372	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASR—atherosclerosis	7.22e-06	0.000372	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.09e-06	0.000365	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CX3CL1—atherosclerosis	7.08e-06	0.000365	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCG1—atherosclerosis	7.06e-06	0.000364	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LCAT—atherosclerosis	7.05e-06	0.000363	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—FABP4—atherosclerosis	7.05e-06	0.000363	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—HMOX1—atherosclerosis	7.03e-06	0.000362	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—EDN1—atherosclerosis	7.01e-06	0.000361	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ABCA1—atherosclerosis	7.01e-06	0.000361	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AGT—atherosclerosis	7e-06	0.000361	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	6.96e-06	0.000359	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CCL5—atherosclerosis	6.96e-06	0.000359	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA4—atherosclerosis	6.92e-06	0.000356	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APOE—atherosclerosis	6.86e-06	0.000353	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CAV1—atherosclerosis	6.8e-06	0.00035	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP7A1—atherosclerosis	6.79e-06	0.00035	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APOA1—atherosclerosis	6.78e-06	0.000349	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOB—atherosclerosis	6.73e-06	0.000347	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CNR2—atherosclerosis	6.71e-06	0.000346	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCL8—atherosclerosis	6.71e-06	0.000346	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MMP3—atherosclerosis	6.7e-06	0.000345	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	6.7e-06	0.000345	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	6.68e-06	0.000344	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LCAT—atherosclerosis	6.64e-06	0.000342	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—FABP4—atherosclerosis	6.64e-06	0.000342	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PRKCG—atherosclerosis	6.62e-06	0.000341	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTM1—atherosclerosis	6.55e-06	0.000337	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA4—atherosclerosis	6.52e-06	0.000336	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—LPL—atherosclerosis	6.43e-06	0.000331	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	6.43e-06	0.000331	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	6.4e-06	0.00033	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EDN1—atherosclerosis	6.37e-06	0.000328	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	6.34e-06	0.000326	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCL5—atherosclerosis	6.32e-06	0.000326	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP27A1—atherosclerosis	6.28e-06	0.000323	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GPX1—atherosclerosis	6.27e-06	0.000323	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CG—atherosclerosis	6.19e-06	0.000319	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	6.16e-06	0.000317	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	6.15e-06	0.000317	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CD36—atherosclerosis	6.11e-06	0.000315	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—HMOX1—atherosclerosis	6.01e-06	0.00031	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PRKCG—atherosclerosis	6.01e-06	0.00031	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VWF—atherosclerosis	5.98e-06	0.000308	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARG—atherosclerosis	5.98e-06	0.000308	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	5.95e-06	0.000307	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA2—atherosclerosis	5.95e-06	0.000307	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	5.95e-06	0.000307	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALOX15—atherosclerosis	5.95e-06	0.000307	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOC3—atherosclerosis	5.95e-06	0.000306	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	5.92e-06	0.000305	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LDLR—atherosclerosis	5.91e-06	0.000304	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCG5—atherosclerosis	5.88e-06	0.000303	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—INS—atherosclerosis	5.86e-06	0.000302	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AGT—atherosclerosis	5.82e-06	0.0003	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MTHFR—atherosclerosis	5.79e-06	0.000298	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL3—atherosclerosis	5.77e-06	0.000297	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOB—atherosclerosis	5.76e-06	0.000297	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	5.74e-06	0.000296	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARA—atherosclerosis	5.68e-06	0.000293	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LPA—atherosclerosis	5.68e-06	0.000292	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALOX15—atherosclerosis	5.61e-06	0.000289	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA2—atherosclerosis	5.61e-06	0.000289	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	5.61e-06	0.000289	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	5.61e-06	0.000289	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—atherosclerosis	5.6e-06	0.000289	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCG5—atherosclerosis	5.54e-06	0.000285	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NCF1—atherosclerosis	5.53e-06	0.000285	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AGT—atherosclerosis	5.5e-06	0.000283	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—BGN—atherosclerosis	5.5e-06	0.000283	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—LPL—atherosclerosis	5.5e-06	0.000283	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA5—atherosclerosis	5.44e-06	0.00028	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOE—atherosclerosis	5.39e-06	0.000278	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—F2—atherosclerosis	5.38e-06	0.000277	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—atherosclerosis	5.37e-06	0.000277	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GPX1—atherosclerosis	5.37e-06	0.000276	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LPA—atherosclerosis	5.35e-06	0.000276	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CAV1—atherosclerosis	5.34e-06	0.000275	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOA1—atherosclerosis	5.33e-06	0.000274	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AGT—atherosclerosis	5.29e-06	0.000272	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	5.24e-06	0.00027	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CD36—atherosclerosis	5.23e-06	0.000269	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDNRA—atherosclerosis	5.22e-06	0.000269	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCR2—atherosclerosis	5.22e-06	0.000269	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CYBA—atherosclerosis	5.2e-06	0.000268	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.19e-06	0.000267	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—BGN—atherosclerosis	5.18e-06	0.000267	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—atherosclerosis	5.15e-06	0.000265	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NOS3—atherosclerosis	5.14e-06	0.000265	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA5—atherosclerosis	5.13e-06	0.000264	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PARP1—atherosclerosis	5.09e-06	0.000262	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PLAT—atherosclerosis	5.09e-06	0.000262	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GHRL—atherosclerosis	5.09e-06	0.000262	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALOX5—atherosclerosis	5.06e-06	0.000261	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—atherosclerosis	4.95e-06	0.000255	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	4.94e-06	0.000254	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—F2—atherosclerosis	4.89e-06	0.000252	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.87e-06	0.000251	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	4.86e-06	0.000251	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARA—atherosclerosis	4.86e-06	0.00025	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALOX5—atherosclerosis	4.77e-06	0.000246	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AGT—atherosclerosis	4.7e-06	0.000242	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—atherosclerosis	4.7e-06	0.000242	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARG—atherosclerosis	4.7e-06	0.000242	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	4.68e-06	0.000241	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOE—atherosclerosis	4.61e-06	0.000237	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—INS—atherosclerosis	4.6e-06	0.000237	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CAV1—atherosclerosis	4.57e-06	0.000235	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOA1—atherosclerosis	4.56e-06	0.000235	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NAMPT—atherosclerosis	4.54e-06	0.000234	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LIPC—atherosclerosis	4.51e-06	0.000232	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOC3—atherosclerosis	4.48e-06	0.000231	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KNG1—atherosclerosis	4.47e-06	0.00023	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LDLR—atherosclerosis	4.46e-06	0.00023	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGTR1—atherosclerosis	4.44e-06	0.000229	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCL2—atherosclerosis	4.35e-06	0.000224	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CETP—atherosclerosis	4.35e-06	0.000224	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PLG—atherosclerosis	4.33e-06	0.000223	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NAMPT—atherosclerosis	4.28e-06	0.00022	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.27e-06	0.00022	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LIPC—atherosclerosis	4.25e-06	0.000219	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOC3—atherosclerosis	4.22e-06	0.000218	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—atherosclerosis	4.22e-06	0.000217	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LDLR—atherosclerosis	4.2e-06	0.000216	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SCARB1—atherosclerosis	4.17e-06	0.000215	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	4.16e-06	0.000214	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CETP—atherosclerosis	4.1e-06	0.000211	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	4.1e-06	0.000211	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NOS3—atherosclerosis	4.04e-06	0.000208	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARG—atherosclerosis	4.02e-06	0.000207	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP3—atherosclerosis	3.96e-06	0.000204	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF2—atherosclerosis	3.94e-06	0.000203	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—INS—atherosclerosis	3.94e-06	0.000203	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMGCR—atherosclerosis	3.94e-06	0.000203	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SCARB1—atherosclerosis	3.93e-06	0.000202	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.86e-06	0.000199	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOB—atherosclerosis	3.82e-06	0.000197	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	3.79e-06	0.000195	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDN1—atherosclerosis	3.76e-06	0.000194	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL5—atherosclerosis	3.73e-06	0.000192	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMGCR—atherosclerosis	3.71e-06	0.000191	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—atherosclerosis	3.69e-06	0.00019	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LPL—atherosclerosis	3.65e-06	0.000188	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—atherosclerosis	3.61e-06	0.000186	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	3.55e-06	0.000183	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCA1—atherosclerosis	3.51e-06	0.000181	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SPP1—atherosclerosis	3.46e-06	0.000178	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NOS3—atherosclerosis	3.45e-06	0.000178	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	3.44e-06	0.000177	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCA1—atherosclerosis	3.31e-06	0.00017	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	3.2e-06	0.000165	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—atherosclerosis	3.16e-06	0.000163	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGT—atherosclerosis	3.12e-06	0.000161	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOE—atherosclerosis	3.06e-06	0.000158	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LEP—atherosclerosis	3.06e-06	0.000158	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CAV1—atherosclerosis	3.03e-06	0.000156	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOA1—atherosclerosis	3.03e-06	0.000156	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMOX1—atherosclerosis	3.01e-06	0.000155	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ESR1—atherosclerosis	2.92e-06	0.00015	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—F2—atherosclerosis	2.89e-06	0.000149	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOB—atherosclerosis	2.88e-06	0.000148	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.84e-06	0.000146	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—atherosclerosis	2.8e-06	0.000144	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	2.76e-06	0.000142	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LPL—atherosclerosis	2.75e-06	0.000142	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOB—atherosclerosis	2.72e-06	0.00014	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPX1—atherosclerosis	2.69e-06	0.000138	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	2.65e-06	0.000136	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—atherosclerosis	2.64e-06	0.000136	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CD36—atherosclerosis	2.62e-06	0.000135	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—INS—atherosclerosis	2.61e-06	0.000135	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LPL—atherosclerosis	2.59e-06	0.000134	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL2—atherosclerosis	2.57e-06	0.000132	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX1—atherosclerosis	2.53e-06	0.00013	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1—atherosclerosis	2.53e-06	0.00013	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—atherosclerosis	2.48e-06	0.000128	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CD36—atherosclerosis	2.46e-06	0.000127	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARA—atherosclerosis	2.43e-06	0.000125	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	2.4e-06	0.000124	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—atherosclerosis	2.36e-06	0.000122	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AGT—atherosclerosis	2.36e-06	0.000121	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.34e-06	0.00012	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOE—atherosclerosis	2.31e-06	0.000119	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOS3—atherosclerosis	2.29e-06	0.000118	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARA—atherosclerosis	2.29e-06	0.000118	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAV1—atherosclerosis	2.29e-06	0.000118	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA1—atherosclerosis	2.28e-06	0.000117	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AGT—atherosclerosis	2.22e-06	0.000114	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOE—atherosclerosis	2.17e-06	0.000112	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAV1—atherosclerosis	2.15e-06	0.000111	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA1—atherosclerosis	2.15e-06	0.000111	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.08e-06	0.000107	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	2.03e-06	0.000105	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARG—atherosclerosis	2.01e-06	0.000104	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—INS—atherosclerosis	1.97e-06	0.000102	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	1.96e-06	0.000101	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.96e-06	0.000101	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—atherosclerosis	1.93e-06	9.96e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARG—atherosclerosis	1.89e-06	9.76e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—INS—atherosclerosis	1.86e-06	9.57e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—atherosclerosis	1.86e-06	9.56e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—atherosclerosis	1.84e-06	9.47e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	1.82e-06	9.37e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—atherosclerosis	1.81e-06	9.31e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	1.79e-06	9.21e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	1.78e-06	9.19e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NOS3—atherosclerosis	1.73e-06	8.9e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—atherosclerosis	1.7e-06	8.77e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	1.65e-06	8.51e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—atherosclerosis	1.64e-06	8.42e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NOS3—atherosclerosis	1.63e-06	8.39e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.59e-06	8.18e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—atherosclerosis	1.58e-06	8.14e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.56e-06	8.05e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.52e-06	7.81e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.49e-06	7.67e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.14e-06	5.88e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.05e-06	5.43e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—atherosclerosis	7.95e-07	4.09e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—atherosclerosis	7.49e-07	3.86e-05	CbGpPWpGaD
